Intellectual Property
Multimeric has exclusive licenses for all therapeutic uses of the following issued and pending patent families in all territories worldwide, including the U.S., Europe, Canada, China, Japan, Korea, Brazil, South Africa, Israel, and Australia:
Issued Patents
US 7,300,774, November 27, 2007 (1.8 MB PDF)
US 7,332,298, February 19, 2008, Division of US 7,300,774 with nucleic acid claims (1.8 MB PDF)
EP1235853B1, July 22, 2009 (1.7 MB PDF)
EP1235853B1, May 28, 2008 (0.7 MB PDF) [exclusive of MegaFasL, APO010]
Patent Applications
US 2009/0081157 A1, published March 26, 2009 (2.5 MB PDF)
